Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells

International Immunology

Volumn 19, Issue 4, 2007, Pages 411-426

  Jung, In Duk ^a   Lee, Jun Sik ^a   Kim, Yong Joo ^a   Jeong, Young Il ^a   Lee, Chang Min ^a   Baumruker, Thomas ^b   Billlich, Andreas ^b   Banno, Yoshiko ^c   Lee, Min Goo ^d   Ahn, Soon Choel ^a   Park, Won Sun ^e   Han, Jin ^e   Park, Yeong Min ^a  

^a Pusan National University   (South Korea)

^b Novartis Institutes for BioMedical Research Vienna   (Austria)

^c GIFU UNIVERSITY   (Japan)

^d Korea University College of Medicine   (South Korea)

^e Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SPHINGOSINE DERIVATIVE; SPHINGOSINE KINASE; SPHINGOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW; C57BL MOUSE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOPHARMACOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TH1 CELL;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BONE MARROW CELLS; CELL AGGREGATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENZYME INHIBITORS; FLOW CYTOMETRY; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID; RNA, SMALL INTERFERING; SPHINGOSINE; TH1 CELLS; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 34047114465     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm006     Document Type: Article

References (55)

1. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685.
2. Banchereau, J., Briere, F., Caux, C. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
3. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
4. Randolph, G. J., Angeli, V. and Swartz, M. A. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5:617.
5. Jin, Y., Knudsen, E., Wang, L. et al. 2003. Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 101:4909.
6. Baumruker, T. and Prieschl, E. E. 2002. Sphingolipids and the regulation of the immune response. Semin. Immunol. 14:57.
7. Spiegel, S. 1999. Sphingosine 1-phosphate: A prototype of a new class of second messengers. J. Leukoc. Biol. 65:341.
8. Ott, V. L. and Cambier, J. C. 2002. Introduction: Multifaceted roles of lipids and their catabolites in immune cell signaling. Semin. Immunol. 14:1.
9. Idzko, M., Panther, E., Corinti, S. et al. 2002. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 16:625.
10. Czeloth, N., Bernhardt, G., Hofmann, F., Genth, H. and Forster, R. 2005. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol. 175:2960.
11. Eigenbrod, S., Derwand, R., Jakl, V., Endres, S. and Eigler, A. 2006. Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. Immunol. Invest. 35:149.
12. Franchi, L., Malisan, F., Tomassini, B. and Testi, R. 2006. Ceramide catabolism critically controls survival of human dendritic cells. J. Leukoc. Biol. 79:166.
13. Igarashi, Y., Hakomori, S., Toyokuni, T. et al. 1989. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 28: 6796.
14. Megidish, T., White, T., Takio, K., Titani, K., Igarashi, Y. and Hakomori, S. 1995. The signal modulator protein 14-3-3 is a target of sphingosine- or N, N-dimethylsphingosine-dependent kinase in 3T3(A31) cells. Biochem. Biophys. Res. Commun. 216:739.
15. King, C. C., Zenke, F. T., Dawson, P. E. et al. 2000. Sphingosine is a novel activator of 3-phosphoinositide-dependent kinase 1. J. Biol. Chem. 275:18108.
16. McDonald, O. B., Hannun, Y. A., Reynolds, C. H. and Sahyoun, N. 1991. Activation of casein kinase II by sphingosine. J. Biol. Chem. 266:21773.
17. French, K. J., Schrecengost, R. S., Lee, B. D. et al. 2003. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63:5962.
18. Murate, T., Banno, Y. K. et al. 2001. Cell type-specific localization of sphingosine kinase 1a in human tissues. J. Histochem. Cytochem. 49:845.
19. Inaba, K., Inaba, M., Romani, N. et al. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
20. Billich, A., Bornancin, F., Mechtcheriakova, D., Natt, F., Huesken, D. and Baumruker, T. 2005. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: Function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell. Signal. 17:1203.
21. Lyons, A. B. 2000. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243:147.
22. Olivera, A., Kohama, T., Tu, Z., Milstien, S. and Spiegel, S. 1998. Purification and characterization of rat kidney sphingosine kinase. J. Biol. Chem. 273:12576.
23. Wu, W., Mosteller, R. D. and Broek, D. 2004. Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol. Cell. Biol. 24:7359.
24. Rosenfeldt, H. M., Hobson, J. P., Maceyka, M. et al. 2001. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. FASEB J. 15:2649.
25. Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A. and Obeid, L. M. 2002. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 277: 35257.
26. de Jong, E. C., Smits, H. H. and Kapsenberg, M. L. 2005. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26:289.
27. Langrish, C. L., McKenzie, B. S., Wilson, N. J., de Waal Malefyt, R., Kastelein, R. A. and Cua, D. J. 2004. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol. Rev. 202:96.
28. Oppmann, B., Lesley, R., Blom, B. et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715.
29. Parham, C., Chirica, M., Timans, J. et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699.
30. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
31. Rescigno, M., Martino, M., Sutherland, C. L., Gold, M. R. and Ricciardi-Castagnoli, P. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:2175.
32. An, H., Yu, Y., Zhang, M. et al. 2002. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106:38.
33. Lin, C. I., Chen, C. N., Chen, J. H. and Lee, H. 2006. Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J. Cell. Biochem. 99:1216.
34. Oz-Arslan, D., Ruscher, W., Myrtek, D. et al. 2006. IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids. J. Leukoc. Biol. 80:287.
35. Renkl, A., Berod, L., Mockenhaupt, M. et al. 2004. Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. Int. J. Mol. Med. 13:203.
36. Davis, M. D., Clemens, J. J., Macdonald, T. L. and Lynch, K. R. 2005. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 280:9833.
37. Spiegel, S. and Milstien, S. 2003. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat. Rev. Mol. Cell. Biol. 4:397.
38. Saba, J. D. and Hla, T. 2004. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ. Res. 94:724.
39. Anliker, B. and Chun, J. 2004. Lysophospholipid G protein-coupled receptors. J. Biol. Chem. 279:20555.
40. Arrighi, J. F., Rebsamen, M., Rousset, F., Kindler, V. and Hauser, C. 2001. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J. Immunol. 166:3837.
41. Shlomchik, W. D., Couzens, M. S., Tang, C. B. et al. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412.
42. Kadowaki, N., Antonenko, S., Ho, S. et al. 2001. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193:1221.
43. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
44. Triantaphyllopoulos, K. A., Williams, R. O., Tailor, H. and Chernajovsky, Y. 1999. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy. Arthritis Rheum. 42:90.
45. Antony, P. A., Piccirillo, C. A., Akpinarli, A. et al. 2005. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol. 174:2591.
46. Rocha, B. and Tanchot, C. 2004. Towards a cellular definition of CD8+ T-cell memory: The role of CD4+ T-cell help in CD8+ T-cell responses. Curr. Opin. Immunol. 16:259.
47. Smith, C. M., Wilson, N. S., Waithman, J. et al. 2004. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5:1143.
48. Murphy, C. A., Langrish, C. L., Chen, Y. et al. 2003. Divergent proand antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951.
49. Xia, P., Gamble, J. R., Rye, K. A. et al. 1998. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl Acad. Sci. USA 95:14196.
50. Shatrov, V. A., Lehmann, V. and Chouaib, S. 1997. Sphingosine-1- phosphate mobilizes intracellular calcium and activates transcription factor NF-kappa B in U937 cells. Biochem. Biophys. Res. Commun. 234:121.
51. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135.
52. O'Neill, L. A. 2006. How Toll-like receptors signal: What we know and what we don't know. Curr. Opin. Immunol. 18:3.
53. Murata, N., Sato, K., Kon, J. et al. 2000. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352 (Pt 3):809.
54. Yatomi, Y., Ohmori, T., Rile, G. et al. 2000. Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96:3431.
55. Windh, R. T., Lee, M. J., Hla, T., An, S., Barr, A. J. and Manning, D. R. 1999. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J. Biol. Chem. 274: 27351.